Biolinerx earnings were -$9.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BLRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$4.3M, up 67.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BLRX reported annual earnings of -$1.2M, with -87.3% growth. The next BLRX earnings date is Nov 23, 2026.
On BLRX's earnings call on Aug 31, 2026, Biolinerx (NASDAQ: BLRX) reported Q2 2026 earnings per share (EPS) of $0.00, up N/A year over year. Total BLRX earnings for the quarter were -$4.34 million. In the same quarter last year, Biolinerx's earnings per share (EPS) was $0.00.
The next BLRX earnings call is Nov 23, 2026. Add BLRX to your watchlist to be reminded of Biolinerx's next earnings date.
Is Biolinerx profitable or losing money?
As of the last Biolinerx earnings report, Biolinerx is currently losing money. Biolinerx's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$9.29 million, a 18.75% increase year over year.
What was BLRX's earnings growth in the past year?
As of Biolinerx's earnings date in Aug 31, 2026, Biolinerx's earnings has grown year over year. BLRX earnings in the past year totalled -$9.29 million.
What are Biolinerx's earnings expectations?
The current EPS estimate for Biolinerx's earnings report in Nov 23, 2026 is -$0.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.